@dave30th Ooof. People in my office are wondering why I have tears streaming down my face right now. .
https://us02web.zoom.us/meeting/register/tZwsdO6gqjMuEtLm13fFAX_5RnkoX6WB0-yK#/registration 2025 GNG-INA Monthly Academic Meetings - 24 April 2025 Description GNG-INA Monthly Academic Meeting – Thursday 24 April 2025 Note: Slight time change this month – all times below in UK Time – Check your local time zone using this Timezone Helper: www.worldtimebuddy.com 11:30AM - 12:15PM – Webinar Title: The de-mystification of Myalgic encephalomyelitis/Chronic Fatigue Syndrome. Dr Lyndal Van Leer, Specialist Neurologist, Queensland, Australia Neurologist and epilepsy sub-specialist working on the Gold Coast, Australia. She has completed two Epilepsy fellowships at Austin health in Melbourne, Australia and currently head the Eletrophysiology-EEG department at Gold Coast University Health. She is particularly interested in disorders of autonomic dysfunction particularly in the post Covid Era. 12:15PM - 1:00PM – Case Presentation Title: Physician assisted suicide and Physician- assisted euthanasia: evidence from abroad and implications for UK physicians Dr Uma Nath, Consultant Neurologist and Parkinson's disease specialist, Sunderland, United Kingdom Uma Nath is a Consultant neurologist from Sunderland, UK. Specialist in Parkinson's disease and Movement disorders. She trained in Edinburgh, London and Newcastle and qualified from Newcastle University. She has a MD in Progressive supranuclear palsy. Uma is Parkinson's research lead in Sunderland and South Tyneside. Member of Association of British Neurologists Advisory Group on Movement disorders and have worked with NICE as expert witness for approval of Produodopa in UK. Uma lectures and educates on behalf of Abbvie ltd on Produodopa. Dr Nath presented keynote lecture at ABN conference 2019 on Assisted Dying and published in this field 2021 Practical Neurology. She is President of Parkinson's UK Sunderland branch. Session Chair: Prof Vaughan Bell, Professor of Clinical Psychology and Cognitive Neuropsychiatry, London United Kingdom He is also a neuropsychologist working between psychosis and neuropsychiatry services at the Maudsley https://bsky.app/profile/gng2020.bsky.social/post/3lmwly5ljuk2p
Canberra Daily: Queensland Government to destroy ‘globally significant’ Covid vaccine study biobank A ‘globally significant’ bank of biosamples from a study into the immune effects of Covid vaccines is set to be destroyed, two years after the award-winning research project was defunded by the Queensland Government.
«The killer must have changed his clothes and shaved his beard by now, so we don’t need the surveillance footage anymore».
Can the national government take it over from the Queensland government? It sounds like a political, not a scientific decision.
Submission from RACGP to NHMRC in response to the scoping survey for the development of clinical practice guidelines for ME/CFS: Link | Full letter (PDF)
Posts on the NHMRC Guideline have been moved to Australia: National Health and Medical Research Council (NHMRC): Development of ME/CFS guidelines
Not a recommendation: https://fortifyfitness.com.au/the-role-of-active-rehabilitation-in-managing-chronic-fatigue/ The Role Of Active Rehabilitation In Managing Chronic Fatigue Emma Bradwell October 1, 2024 Breaking the Boom-Bust Cycle: The Role of Active Rehabilitation in Managing Chronic Fatigue Introduction Chronic fatigue syndrome (CFS) is characterised by persistent fatigue that interferes with daily activities and is not alleviated by rest (Fukuda et al., 1994). This condition goes beyond just feeling tired and encompasses a wide variety of debilitating symptoms. The causes of CFS are not yet fully understood but for some people it can follow infection, toxic exposure, anaesthetic, immunisation, or trauma such as car accident. Patients often experience a “boom-bust” cycle—periods of increased activity followed by exacerbation of symptoms, leading to a cycle of overexertion and subsequent fatigue. This article discusses how active rehabilitation can help mitigate this cycle, improve overall exercise capacity, and enhance quality of life for individuals with chronic fatigue. Continues at: https://fortifyfitness.com.au/the-role-of-active-rehabilitation-in-managing-chronic-fatigue/
Mason Foundation awards $1.44 million to fight chronic fatigue https://www.eqt.com.au/mediacentre/...-awards-1-44-million-to-fight-chronic-fatigue Approximately $1.44 million has been committed to support vital Australian research into Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS). The Judith Jane Mason & Harold Stannett Williams Memorial Foundation (the Mason Foundation) is a charitable trust established by a generous donation in 2003 by Judith Jane Mason (née Williams) and named in honour of her father Harold Stannett Williams. ME/CFS is a complex and debilitating condition, characterised by profound fatigue, cognitive impairment, and other symptoms that worsen with physical or mental exertion and don't improve with rest. Secondary symptoms may include gastrointestinal disorders, muscle and joint pain and immune impairments. The Mason Foundation was one of the first philanthropic funders to recognise the importance of ME/CFS research, with funding directed to solving the ongoing challenge of this elusive illness, which has a devastating impact on the lives of many. The 2025 ME/CFS research grants program will fund each of the following projects over the next three years: Dr Katherine Huang, University of Melbourne – Predicting post-exertional malaise in ME / CFS with digital biomarkers – $360,000 Dr Francesca Alves, The Florey Institute of Neuroscience and Mental Health – Modelling and treating energy deficiency in myalgic encephalomyelitis / chronic fatigue syndrome (ME / CFS) – $359,970 Dr Benjamin Heng, Macquarie University - Validating a novel blood-based biological signature to diagnose and manage myalgic encephalomyelitis / chronic fatigue syndrome (ME / CFS) – $356,694 Dr Sarah Annesley, La Trobe University – miRNA alterations in ME / CFS: Unpacking the role of S6K, viruses and metabolism – $359,405. Since establishment 22 years ago, the Mason Foundation has awarded more than $27 million of research funding for ME/CFS and also Alzheimer’s disease. Emily Cormack, National Manager, Social Impact Team at Equity Trustees, said, “The Mason Foundation grants provide much needed and significant funding for research into a condition that is not well understood. Diagnosis is a challenge in the absence of a diagnostic test and of a universally accepted case definition among researchers and clinicians.” “The Mason Foundation has provided continuous funding since 2005 for research into ME/CFS. We are hopeful that the ME/CFS competitive grant scheme will help our understanding of this poorly understood condition which impacts so many lives,” Ms Cormack said.
Looks cool Guessing this is BPS? Edit: Nevermind, definitely not BPS. Seems to be looking at muscles https://florey.edu.au/news/2025/01/finding-the-cause-for-energy-loss-in-chronic-fatigue-syndrome/
